JOSEPH KANNARKATT, M.D.
Hematology & Oncology Physician · YORK, PA
Individual Active NPI 1124311956
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 875 | 145,386 | $6,216,191 | $4,071,096 | $3,242,119 |
| 2023 | 910 | 156,453 | $5,889,410 | $3,508,894 | $2,796,426 |
| 2022 | 814 | 140,388 | $5,149,637 | $3,162,706 | $2,526,252 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 19,075 | $3 | $2 |
| J9299 | Injection, nivolumab, 1 mg | 12,220 | $31 | $25 |
| J9271 | Injection, pembrolizumab, 1 mg | 11,600 | $50 | $40 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,340 | $49 | $39 |
| J9025 | Injection, azacitidine, 1 mg | 9,100 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 7,080 | $26 | $21 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 4,500 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 3,450 | $0 | $0 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 3,100 | $20 | $16 |
| J9041 | Injection, bortezomib, 0.1 mg | 1,925 | $2 | $1 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,597 | $0 | $0 |
| 36415 | Insertion of needle into vein for collection of blood sample | 1,482 | $9 | $9 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | MD462352 | PA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Pennsylvania
- NPI 1750380036
- NPI 1134324536
- NPI 1942209234
- NPI 1396783122
- NPI 1346635679
- NPI 1679749121
- NPI 1538663208
- NPI 1285991638
See all Hematology & Oncology Physician providers in Pennsylvania →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.